Literature DB >> 907949

Portal hypertension complicating myelofibrosis: reversal following splenectomy.

B E Lukie, R T Card.   

Abstract

Portal hypertension occurs in approximately 10% of patients with myelofibrosis. Increased portal blood flow secondary to splenomegaly has been proposed to explain its development. In a 60-year-old woman with proven myelofibrosis of 10 years' duration and gross splenomegaly, portal hypertension developed with esophageal varices and ascites. There was no demonstrable obstruction to portal blood flow. Following splenectomy the ascites and esophageal varices disappeared. Despite the presence of splenic myeloid metaplasia, splenectomy did not impair the patient's hematologic status. Portal hypertension complicating myelofibrosis has a poor prognosis, so careful attention should be given to its detection. Splenectomy may be preferable to portal-systemic shunting in the management of this complication.

Entities:  

Mesh:

Year:  1977        PMID: 907949      PMCID: PMC1880077     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  10 in total

1.  Myelofibrosis. Clinical, hematologic and pathologic study of 110 patients.

Authors:  B A BOURONCLE; C A DOAN
Journal:  Am J Med Sci       Date:  1962-06       Impact factor: 2.378

2.  Agnogenic myeloid metaplasia. A survey of twenty-nine cases and a review of the literature.

Authors:  G S NAKAI; C G CRADDOCK; W G FIGUEROA
Journal:  Ann Intern Med       Date:  1962-09       Impact factor: 25.391

3.  Gastrointestinal and abdominal manifestations of agnogenic myeloid metaplasia.

Authors:  M N Silverstein; E E Wollaeger; A H Baggenstoss
Journal:  Arch Intern Med       Date:  1973-04

4.  Esophageal varices in agnogenic myeloid metaplasia: disappearance after splenectomy. A case report.

Authors:  A Sullivan; H Rheinlander; L R Weintraub
Journal:  Gastroenterology       Date:  1974-03       Impact factor: 22.682

5.  Sex, splenectomy, and myeloid metaplasia.

Authors:  M N Silverstein; W H ReMine
Journal:  JAMA       Date:  1974-01-28       Impact factor: 56.272

6.  Spleen blood flow and splanchnic haemodynamics in blood dyscrasia and other splenomegalies.

Authors:  L M Blendis; D C Banks; C Ramboer; R Williams
Journal:  Clin Sci       Date:  1970-01       Impact factor: 6.124

7.  Ascites in myeloid metaplasia due to ectopic peritoneal implantations.

Authors:  D Gorshein; M J Brauer
Journal:  Cancer       Date:  1969-06       Impact factor: 6.860

8.  Hemodynamic studies of the portal circulation in myeloid metaplasia.

Authors:  D L Rosenbaum; G W Murphy; S N Swisher
Journal:  Am J Med       Date:  1966-09       Impact factor: 4.965

9.  Myeloproliferative disorders.

Authors:  S I Schwartz
Journal:  Ann Surg       Date:  1975-10       Impact factor: 12.969

10.  Portal hypertension in the myeloproliferative syndrome and the reticuloses.

Authors:  S SHALDON; S SHERLOCK
Journal:  Am J Med       Date:  1962-05       Impact factor: 4.965

  10 in total
  7 in total

1.  Esophageal variceal ligation for esophageal variceal hemorrhage in a patient with portal and primary pulmonary hypertension complicating myelofibrosis.

Authors:  W C Lee; H C Lin; S H Tsay; Y Y Yang; M C Hou; F Y Lee; F Y Chang; S D Lee
Journal:  Dig Dis Sci       Date:  2001-04       Impact factor: 3.199

2.  Synergism between hepatocellular injury and shunting in portosystemic encephalopathy (PSE): case report of acute brittle TIPS-induced PSE.

Authors:  Gil Weitzman; Neil J Schamberg; Gerond Lake-Bakaar
Journal:  Dig Dis Sci       Date:  2007-07-20       Impact factor: 3.199

3.  Clinical features of patients with Philadelphia-negative myeloproliferative neoplasms complicated by portal hypertension.

Authors:  Matthew Yan; Holly Geyer; Ruben Mesa; Ehab Atallah; Jeannie Callum; Justyna Bartoszko; Karen Yee; Manjula Maganti; Florence Wong; Vikas Gupta
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2014-06-11

4.  Portal hypertension secondary to myelofibrosis with myeloid metaplasia: a study of 13 cases.

Authors:  Mohannad Abu-Hilal; Jayant Tawaker
Journal:  World J Gastroenterol       Date:  2009-07-07       Impact factor: 5.742

5.  Multiple esophageal variceal ruptures with massive ascites due to myelofibrosis-induced portal hypertension.

Authors:  Koichi Tokai; Hiroyuki Miyatani; Yukio Yoshida; Shigeki Yamada
Journal:  World J Gastroenterol       Date:  2012-07-28       Impact factor: 5.742

6.  Endoscopic injection sclerotherapy for esophageal variceal hemorrhage in myeloproliferative disorder: case report.

Authors:  M Matsumoto; H Matsumoto; T Miyake; K Nakao; K Iwata; N Yoshida; K Kanai
Journal:  J Gastroenterol       Date:  1995-04       Impact factor: 7.527

7.  Pulmonary hypertension with massive megalosplenia: A case report.

Authors:  Tieci Yi; Wei Ma; Jianxing Qiu; Wenhui Ding
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.889

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.